Back to Carlyle Group Inc. Carlyle Group Inc.

QTTBQTTB
10 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in Q32 BIO INC

Carlyle Group Inc. holds 60,363 shares of QTTB (Q32 BIO INC), worth $769,020 as of 2026-Q2. The position was decreased (-94.5% shares). QTTB represents 0.0% of Carlyle Group Inc.'s portfolio.

Current Value

$769,020

Current Shares

60,363

Total Value Change

-$17.3M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
60,363
-94.5%
$769,0200.0%$12.74
0
2026-Q1
Unchanged
1.1M
0.0%
$7.1M0.1%$4.89
0
2025-Q4
Unchanged
1.1M
0.0%
$3.6M0.0%$3.20
0
2025-Q3
Unchanged
1.1M
0.0%
$2.1M0.0%$1.94
0
2025-Q2
Unchanged
1.1M
0.0%
$1.6M0.0%$1.45
0
2025-Q1
Unchanged
1.1M
0.0%
$1.8M0.0%$1.71
0
2024-Q4
Unchanged
1.1M
0.0%
$3.8M0.1%$3.11
0
2024-Q3
Unchanged
1.1M
0.0%
$48.6M5.1%$46.00
0
2024-Q2
Unchanged
1.1M
0.0%
$19.2M1.8%$17.95
0
2024-Q1
New
1.1M
-
$18.1M1.1%$17.04
66

Other major holders of QTTB: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P., Temasek Holdings (Private) Ltd, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used